老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

157.72
-0.4250-0.27%
成交量：9.57万
成交额：1,511.82万
市值：94.83亿
市盈率：-23.33
高：159.47
开：159.47
低：155.54
收：158.14
数据加载中...
总览公司新闻公告
2020/03/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多